On Medicare? Explore the $50/month medication copay program

GLP-1 Medication Timeline: Progress & What to Expect

If you've started a GLP-1, or you're deciding whether to, one question comes up more than any other in our practice: how long until this works? Two timelines answer it. The first is the science that brought us here. The second is your own, week by week, once you begin.

This is general education, not medical advice for your specific situation. TOM Weight Loss is a physician-led telehealth practice serving Texas and Utah, led by Dr. Tran Le, MD, DABOM, triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine.

The GLP-1 medication timeline: from lizard venom to modern obesity care

The class traces back to a discovery in the early 1990s. While investigating bioactive peptides in Gila monster venom, John Eng at the Veterans Affairs Medical Center in New York identified exendin-4, a 39 amino acid peptide that behaved like GLP-1 but resisted enzymatic degradation (the process that breaks it down). Your body's own GLP-1 is broken down within minutes.

That finding launched a drug class. On April 28, 2005, the FDA approved exenatide (Byetta), the first GLP-1 receptor agonist approved for clinical use. It was a twice-daily injection. It lowered blood sugar safely, and patients tended to lose some weight.

The engineering then improved steadily. Later medications were built from the human GLP-1 sequence instead of the lizard peptide and last far longer in the body. A few milestones:

  • 2021: The FDA approved semaglutide 2.4 mg injection (Wegovy) for weight management in June 2021.
  • 2022 to 2023: Tirzepatide was approved for type 2 diabetes (Mounjaro) in May 2022 and for weight management (Zepbound) in November 2023. It is the first obesity treatment that activates both GIP and GLP-1 hormone receptors.
  • 2024: The FDA expanded the use of semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, or stroke in adults with cardiovascular disease and overweight or obesity. A cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events compared with placebo.

These medications are the product of three decades of refinement.

How GLP-1 medications actually work

These medications mimic a gut hormone your body already makes. Endogenous GLP-1 is produced in the intestines in response to food. By activating the GLP-1 receptor, the medications increase glucose-dependent insulin secretion, inhibit glucagon release, and slow gastric emptying.

The weight effect comes from several directions at once. In the brain, GLP-1 receptor agonists act on regions that control appetite and energy expenditure. In the body, they improve glycemic control, reduce glucagon, delay gastric emptying, and regulate gut hormones.

They also lower ghrelin, the "hunger hormone" the stomach produces when it is empty, which suppresses appetite. In plain terms, you feel full sooner, stay full longer, and think about food less.

You can read more about the specific options on our medications page, including semaglutide and tirzepatide.

Your personal timeline: what to expect week by week

GLP-1s are not started at full strength. The dose rises gradually over several weeks to months to limit gastrointestinal side effects like nausea while building the therapeutic response. Package-insert guidance for semaglutide and tirzepatide recommends raising the dose every 4 weeks, with the goal of reaching the maximum recommended dose by about the sixth prescription.

The slow ramp shapes what you feel.

Weeks 1 to 4: starting low

This is an adjustment phase. The first 4 to 8 weeks usually use lower "starter" doses so the body can adjust to side effects like nausea. Some people notice reduced appetite early. Many see little movement on the scale yet, which is expected. Real-world data show an average weight change of only about 1% by week 8, which is hard to see day to day.

Weeks 5 to 16: building up

As the dose steps up, appetite effects usually become more noticeable. The early weeks feel modest because the trials that showed substantial weight loss used full maintenance doses over many months. People still titrating at lower doses generally lose weight more slowly.

Reaching maintenance

Open sunlit patio doors leading to a lush morning garden with a stoneware coffee mug on a small wood table
Long-term maintenance is about finding the lowest effective routine that keeps your weight and energy steady.
Meaningful results tend to track with reaching and staying on your maintenance dose. In our practice, patients often do best when they do not rush the titration. Time to therapeutic effect stays similar at roughly 8 to 12 weeks regardless of escalation speed, so a gradual protocol does not cost you time. Faster escalation mostly adds side effects.

This timeline is a general map. Genetics, starting weight, other medications, diet, sleep, and conditions like thyroid disease all affect pace. In a physician-led program, we adjust the plan to the person.

Compounded vs. brand-name options

At TOM Weight Loss, our memberships include compounded semaglutide or tirzepatide with the medication included, and we also offer an à la carte plan for brand-name GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro. Compounded medications are not FDA-approved. You can compare the options and costs on our pricing page.

Frequently asked questions

How long does it take for a GLP-1 to start working?

Many people notice appetite changes within the first one to two weeks. GLP-1 medications typically show initial effects on blood glucose within 1 to 2 weeks and appetite suppression within days to weeks. The full therapeutic response takes longer as the dose rises.

Why am I not losing weight in the first month?

Usually because you are still at a starter dose. The early weeks help your body tolerate the medication, and average changes early on are small and easy to miss. If progress stalls after you reach maintenance, talk with your clinician about dose, diet, and other factors.

Can I speed up my dose to lose weight faster?

Generally no. Faster escalation tends to increase side effects without improving the timeline to therapeutic effect.

Ready to start?

If you're in Texas or Utah, start a consultation with our physician-led team.

Sources

Ready to talk to a board-certified physician?

Explore GLP-1 eligibility and membership pricing for online care in Texas and Utah. Your first visit with Dr. Le is free.

Start your consultation ← Back to all articles